New hope for hodgkin lymphoma: immune therapy after transplant may keep cancer away
NCT ID NCT06812858
First seen May 02, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study is for people with Hodgkin lymphoma that has come back or not responded to treatment. After a stem cell transplant, participants will receive a drug called a PD-1 inhibitor to help keep the cancer from returning. The goal is to see if this maintenance therapy improves how long people live without their cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Medical and Surgical Center named after N.I. Pirogov
RECRUITINGMoscow, Russia
Contact Email: •••••@•••••
-
National Research Oncology Center
RECRUITINGAstana, Kazakhstan
Contact Email: •••••@•••••
-
RM Gorbacheva Research Institute, Pavlov University
RECRUITINGSaint Petersburg, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
RecruitingP. Hertsen Moscow Oncology Research Institute (MORI) for administrative and economic work - the branch of the FSBI "National Medical Research Radiological Centre" (NMRRC) of the Ministry of Health of the Russian Federation
RECRUITINGMoscow, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.